ArticleScientific reports2026

Targeting of CD28 and CD38 as a potential novel therapeutic strategy for peripheral T-cell lymphomas.

Aurélie Dupuy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.